DUBLIN, IRELAND, Oct 06, 2008 (MARKET WIRE via COMTEX) -- Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that Mr. Ronan O'Caoimh, Executive Chairman, has agreed to resume the role of CEO. Mr. O'Caoimh will succeed Mr. Brendan Farrell, who has resigned with immediate effect, having served as Trinity Biotech's President since 1994 and as CEO since November 2007.
